levonorgestrel has been researched along with Postpartum Amenorrhea in 80 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (18.75) | 18.7374 |
| 1990's | 18 (22.50) | 18.2507 |
| 2000's | 17 (21.25) | 29.6817 |
| 2010's | 20 (25.00) | 24.3611 |
| 2020's | 10 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, BA; Creinin, MD; Cwiak, C; Olariu, AI; Schreiber, CA; Turok, DK | 1 |
| Brennan, C; Brunie, A; Chintu, N; Danna, K; Lydon, M; Rademacher, KH; Stankevitz, K | 1 |
| Bertelsen, PK; Heinemeier, IIK; Kragsig Thomsen, T; Messerschmidt, L; Rudnicki, M | 1 |
| Bear, B; Kazak, AE; Schwartz, BI; Short, VL | 1 |
| Chen, BA; Creinin, MD; Eisenberg, DL; Olariu, AI; Schreiber, CA; Turok, DK | 1 |
| Parks, MA; Temkit, M; Zwayne, N | 1 |
| Alexander, M; Breech, LL; Schwartz, BI | 1 |
| Bahamondes, L; Brull, EP; Fernandes, A; Juliato, CRT; Monteiro, I | 1 |
| Sandoval-Vivas, P | 1 |
| Nelson, AL | 1 |
| Creinin, MD; Cwiak, C; Darney, PD; Olariu, A; Stuart, GS; Thomas, MA | 1 |
| Blumenthal, PD; Creinin, MD; Keder, LM; Olariu, AI; Schreiber, CA; Teal, SB | 1 |
| Gao, X; Hubacher, D; Maldonado, LY; Sergison, JE | 1 |
| Creinin, MD; Goldthwaite, LM | 1 |
| Bagchi, T; Bartley, C; Kimble, RMN; Leeks, R; O'Brien, B | 1 |
| Ameye, L; Hindryckx, A; Timmerman, D; Van den Bosch, T; Van Schoubroeck, D; Veldman, J; Werbrouck, E | 1 |
| Bateson, D; McGeechan, K; Mohapatra, L; Weisberg, E | 1 |
| Bekhradi, R; Mohammad-Alizadeh-Charandabi, S; Mohebbi-Kian, E | 1 |
| Schreiber, CA; Sober, S | 1 |
| Bangerter, K; Kroll, R; Lynen, R; Merz, M | 1 |
| Fraser, IS; McGeechan, K; Merki-Feld, GS; Weisberg, E | 1 |
| Baktiroglu, M; Dogan, Y; Kahramanoglu, I; Karateke, A; Senol, T; Suer, N | 1 |
| Pieh Holder, KL | 1 |
| Boccard, S; Farley, T; Landoulsi, S; Meirik, O; Peregoudov, A; Piaggio, G; Rowe, P | 1 |
| Madden, T; McNicholas, C; Mejia, M; Peipert, JF | 1 |
| Constantine, GD; Fortier, MP; Grubb, GS; Mirkin, S; Reid, RL; Smith, L | 1 |
| Hartmann, B; Huber, JC; Kirchengast, S; Stoegerer-Hecher, E | 1 |
| Burock, K; Fraser, IS; Inki, P; Jensen, J; Lukkari-Lax, E; Mansour, D | 1 |
| Abd Alhamid, M; Elyan, A; Ibrahim, A; Ibrahim, EA; Laban, M | 1 |
| Prema, K | 1 |
| Abdalla, MI; Fayad, MM; Ibrahim, II; Shafeek, MA | 1 |
| Lopez, G; Rodriguiz, A | 1 |
| Bahamondes, L; Espejo-Arce, X; Hidalgo, M; Nascimento, R; Perrotti, M; Petta, CA | 1 |
| Baldaszti, E; Löschke, K; Wimmer-Puchinger, B | 1 |
| Ba, MG; Diadhiou, F; Moreau, JC | 1 |
| Bahamondes, L; De Angelo Andrade, LA; Hidalgo, MM; Oliveira-Ribeiro, M; Petta, CA | 1 |
| Chegini, N; Hardt, N; Rhoton-Vlasak, A; Williams, RS | 1 |
| Eriksson, MJ; Hirschberg, AL; Rickenlund, A; Schenck-Gustafsson, K | 1 |
| Baird, DT; Cameron, ST; Dewart, H; Gebbie, A; Glasier, AF | 1 |
| Collinet, P; Cosson, M; Nayama, M | 1 |
| Aldrighi, JM; de Lima, GR; Magalhães, J | 1 |
| Tokhunts, KA | 1 |
| Balogun, OR | 1 |
| Wagstaff, AJ | 1 |
| Haspels, AA | 1 |
| Woutersz, TB | 1 |
| Lähteenmäki, PL; Luukkainen, T; Nilsson, CG | 1 |
| Heikkilä, M; Luukkainen, T | 1 |
| Allonen, H; Diaz, J; Luukkainen, T; Nilsson, CG | 1 |
| Elamsson, K; Englund, DE; Johansson, ED; Odlind, V; Victor, A | 1 |
| Heikkilä, M; Luukkainen, T; Nylander, P | 1 |
| Noerpramana, NP | 1 |
| Hemminki, E; Ollila, E; Sihvo, S | 1 |
| Andersson, K; Odlind, V; Rybo, G | 2 |
| Alvarez, F; Díaz, J; Faúndes, A | 1 |
| Gu, SJ; Shi, SQ; Wang, SL; Xiao, BL; Zhu, PD | 1 |
| Rizk, DE | 1 |
| Chompootaweep, S; Dusitsin, N; Kochagarn, E; Sirisumpan, S; Tang-usaha, J; Theppitaksak, B | 1 |
| Archer, DF; DelConte, A; Maheux, R; O'Brien, FB | 1 |
| Affandi, B | 1 |
| Costa, MM; da Silva, MO | 1 |
| Nawroth, F; Sudik, R | 1 |
| Kaper, RF; Qian, SZ; Sang, GW; Zheng, HM; Zheng, SR | 1 |
| Bisson, D; Bobrow, C; Cooling, H | 1 |
| Affandi, B; Arola, J; Koistinen, H; Koistinen, R; Mandelin, E; Seppälä, M | 1 |
| Bahamondes, L; Dantas-Monteiro, C; Diaz, J; Hidalgo, M; Perrotti, M; Petta, C | 1 |
| Weng, L; Zhang, L | 1 |
| Bahamondes, L; Diaz, J; Monteiro, I; Perrotti, M; Petta, C | 1 |
| Chen, JH; Gao, J; Wang, SL; Wu, SC; Xin, XM | 1 |
| Cook, CE; Darney, PD; Klaisle, CM; Monroe, SE; Phillips, NR; Schindler, A | 1 |
| Alvarez-Sanchez, F; Brache, V; Faúndes, A; Jimenez, E; Tejada, AS | 1 |
| Alvarez, F; Brache, V; Diaz, J; el Mahgoub, S; Faundes, A; Jimenez, E; McCarthy, T; Mishell, DR; Shoupe, D; Sivin, I | 1 |
| Ratnam, SS; Singh, K; Singh, P; Viegas, OA | 1 |
| Fraser, IS | 1 |
| Doornebos, CM; Hamerlynck, JV; Muntendam, P; Vollebregt, JA | 1 |
| Allonen, H; Haukkamaa, M; Lähteenmäki, P; Luukkainen, T; Nilsson, CG; Toivonen, J | 1 |
| Datey, S; Hingorani, V; Jalnawala, SF; Kochhar, M; Mehta, S; Rai Chaudhury, G; Roy, M; Saxena, BN; Saxena, NC; Sengupta, PC | 1 |
7 review(s) available for levonorgestrel and Postpartum Amenorrhea
| Article | Year |
|---|---|
Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years.
Topics: Amenorrhea; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Time Factors | 2017 |
Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis.
Topics: Amenorrhea; Clinical Trials as Topic; Contraceptive Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Time Factors | 2019 |
Postpartum contraception.
Topics: Amenorrhea; Birth Intervals; Breast Feeding; Condoms; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate; Postpartum Period; Sterilization, Tubal; Venous Thromboembolism | 2014 |
Contraception and Breastfeeding.
Topics: Amenorrhea; Breast Feeding; Contraception; Contraception, Postcoital; Contraceptives, Oral; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Postpartum Period; Progesterone; Progestins; Time Factors | 2015 |
Continuous-use ethinylestradiol/levonorgestrel 20microg/90microg: as an oral contraceptive.
Topics: Amenorrhea; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel | 2007 |
NORPLANT and the levonorgestrel IUD in Chinese family planning programmes.
Topics: Amenorrhea; China; Drug Implants; Family Planning Policy; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Pregnancy | 1993 |
An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Desogestrel; Dysmenorrhea; Female; Hemoglobins; Humans; Levonorgestrel; Longitudinal Studies; Medical Records; Menstruation Disturbances; Patient Dropouts; Progesterone Congeners; Randomized Controlled Trials as Topic; Vinyl Compounds | 1998 |
30 trial(s) available for levonorgestrel and Postpartum Amenorrhea
| Article | Year |
|---|---|
Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Multivariate Analysis; Parity; Pregnancy; Regression Analysis; Time Factors; Young Adult | 2018 |
Bleeding patterns for the Liletta
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Middle Aged; Parity; Pregnancy; Prospective Studies; Time Factors; Young Adult | 2018 |
Efficacy of fennel and combined oral contraceptive on depot medroxyprogesterone acetate-induced amenorrhea: a randomized placebo-controlled trial.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Foeniculum; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation; Phytotherapy; Plant Oils; Young Adult | 2014 |
Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menorrhagia; Menstrual Cycle; Metrorrhagia; Norpregnenes; Patient Dropouts; Progestins; Transdermal Patch; United States; Young Adult | 2015 |
Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; New South Wales; Patient Education as Topic; Patient Satisfaction; Self Care; Young Adult | 2015 |
Levonorgestrel-releasing intrauterine device use as an alternative to surgical therapy for uterine leiomyoma.
Topics: Adult; Amenorrhea; Female; Hemoglobins; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Prospective Studies; Uterine Neoplasms | 2015 |
Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Device Removal; Female; Hemorrhage; Humans; Intrauterine Devices, Copper; Levonorgestrel; Patient Safety; Pregnancy; Pregnancy, Unplanned; Proportional Hazards Models; Time Factors | 2016 |
Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Time Factors | 2013 |
Oral contraceptives improve endothelial function in amenorrheic athletes.
Topics: Adolescent; Adult; Amenorrhea; Brachial Artery; Contraceptives, Oral; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Regional Blood Flow; Sports; Vasodilation; Weight-Bearing | 2005 |
Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
Topics: Administration, Cutaneous; Amenorrhea; Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Incidence; Levonorgestrel; Middle Aged; Pilot Projects; Postmenopause; Treatment Outcome; Uterine Hemorrhage | 2006 |
[Acceptability of intrauterine levonorgestrel delivery system (Mirena 52mg) after estrogen-progesterone oral contraception: results of a prospective multicentric study of 211 patients aged 25-35 years].
Topics: Adult; Amenorrhea; Contraception; Contraceptive Agents, Female; Estrogens; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Patient Satisfaction; Progesterone; Prospective Studies | 2006 |
Clinical experience with a low-dose contraceptive agent. European studies.
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Pregnancy; Stereoisomerism | 1983 |
Clinical performance of a new levonorgestrel-releasing intrauterine device. A randomized comparison with a nova-T-copper device.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation; Norgestrel; Random Allocation | 1982 |
Perceptions and satisfaction among Norplant users in Finland.
Topics: Adult; Amenorrhea; Family Planning Services; Female; Finland; Humans; Intrauterine Devices; Levonorgestrel; Maternal Health Services; Patient Satisfaction; Surveys and Questionnaires; Uterine Hemorrhage | 1995 |
Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial.
Topics: Adult; Amenorrhea; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 1994 |
A Latin American experience with levonorgestrel IUD.
Topics: Adult; Amenorrhea; Brazil; Developing Countries; Dominican Republic; Female; Ferritins; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Life Tables; Luteal Phase; Pregnancy | 1993 |
Subdermal levonorgestrel implants. Three years' experience in Cairo, Egypt.
Topics: Administration, Cutaneous; Adult; Amenorrhea; Contraceptive Agents, Female; Drug Implants; Egypt; Family Planning Policy; Female; Headache; Humans; Hypertension; Incidence; Levonorgestrel; Longitudinal Studies; Pregnancy; Pregnancy Rate | 1995 |
Effectiveness of Norplant implants among Thai women in Bangkok.
Topics: Acne Vulgaris; Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Drug Implants; Female; Headache; Humans; Levonorgestrel; Life Tables; Melanosis; Menstrual Cycle; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Pregnancy Rate; Thailand | 1996 |
A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG).
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol Congeners; Ethinyl Estradiol; Female; Headache; Humans; Incidence; Levonorgestrel; Life Tables; Menstruation; Metrorrhagia; Middle Aged; Patient Compliance; Patient Dropouts; Pregnancy; Pregnancy Rate; Safety; Uterine Cervical Neoplasms; Uterine Hemorrhage | 1997 |
Reason, myths and fantasies: preliminary data and reflections about the Portuguese experience with LNG-IUS-induced hypomenorrhea.
Topics: Adult; Amenorrhea; Attitude to Health; Contraceptive Agents, Female; Cultural Characteristics; Drug Delivery Systems; Female; Ferritins; Hemoglobins; Humans; Intrauterine Devices; Levonorgestrel; Menstruation Disturbances; Pilot Projects; Portugal; Premenopause; Social Class | 1999 |
A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
Topics: Adult; Amenorrhea; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Desogestrel; Female; Hemoglobins; Humans; Levonorgestrel; Patient Acceptance of Health Care; Progesterone Congeners; Uterine Hemorrhage; Vinyl Compounds | 1999 |
Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years.
Topics: Adolescent; Adult; Amenorrhea; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Oligomenorrhea; Patient Satisfaction; Pregnancy; Prospective Studies; Uterine Hemorrhage | 2002 |
[Clinical study on women with amenorrhea after levonorgestrel intrauterine system].
Topics: Adult; Amenorrhea; Consumer Product Safety; Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices; Levonorgestrel; Menstruation; Pregnancy; Progesterone Congeners; Time Factors | 2001 |
Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study(1).
Topics: Adult; Amenorrhea; Contraceptives, Oral, Synthetic; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Oligomenorrhea; Pilot Projects; Progesterone Congeners; Prospective Studies | 2002 |
Three years' experience with levonorgestrel-releasing intrauterine device and Norplant-2 implants: a randomized comparative study.
Topics: Adult; Amenorrhea; Contraception; Drug Implants; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Life Tables; Menstruation; Patient Satisfaction; Pregnancy | 1992 |
Evaluation of a 1-year levonorgestrel-releasing contraceptive implant: side effects, release rates, and biodegradability.
Topics: Abdominal Pain; Adolescent; Adult; Amenorrhea; Contraceptive Agents; Drug Evaluation; Drug Implants; Estradiol; Female; Humans; Injections, Subcutaneous; Levonorgestrel; Lipoproteins; Ovarian Cysts; Ovulation; Progesterone; Time Factors | 1992 |
Phase II--clinical trial with biodegradable subdermal contraceptive implant Capronor (4.0-cm single implant). Indian Council of Medical Research Task Force on Hormonal Contraception.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Drug Evaluation; Drug Implants; Female; Humans; Injections, Intradermal; Levonorgestrel; Life Tables | 1991 |
Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
Topics: Adolescent; Adult; Amenorrhea; Copper; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Norgestrel; Patient Dropouts; Pelvic Inflammatory Disease | 1990 |
Five years' experience with levonorgestrel-releasing IUDs.
Topics: Adult; Amenorrhea; Female; Humans; Infections; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy; Random Allocation | 1986 |
Phase II randomized comparative clinical trial of Norplant (six capsules) with Norplant-2 (two covered rods) subdermal implants for long-term contraception: report of a 24-month study. National Programme of Research in Human Reproduction.
Topics: Adolescent; Adult; Amenorrhea; Clinical Trials as Topic; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Oligomenorrhea; Random Allocation; Time Factors | 1986 |
43 other study(ies) available for levonorgestrel and Postpartum Amenorrhea
| Article | Year |
|---|---|
Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use.
Topics: Adolescent; Adult; Amenorrhea; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Young Adult | 2022 |
What are the prospects for the hormonal IUD in the public sector? A mixed-method study of the user population in Zambia.
Topics: Amenorrhea; Contraception; Contraceptive Agents, Female; Female; Hemorrhage; Humans; Intrauterine Devices; Levonorgestrel; Male; Public Sector; Zambia | 2022 |
Impact of combined endometrial resection or ablation and levonorgestrel intrauterine device on postoperative bleeding pattern.
Topics: Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Metrorrhagia; Prospective Studies | 2023 |
General Approaches to Medical Management of Menstrual Suppression: ACOG Clinical Consensus No. 3.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Menstruation | 2022 |
Outcomes of Menstrual Management Use in Transgender and Gender-Diverse Adolescents.
Topics: Adolescent; Amenorrhea; Child; Contraceptive Agents, Female; Female; Hemorrhage; Humans; Infant, Newborn; Intrauterine Devices, Medicated; Levonorgestrel; Norethindrone Acetate; Pain; Retrospective Studies; Transgender Persons | 2023 |
Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Young Adult | 2020 |
Bleeding Patterns among Adolescents Using the Levonorgestrel Intrauterine Device: A Single Institution Review.
Topics: Adolescent; Adult; Amenorrhea; Child; Dose-Response Relationship, Drug; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Male; Menorrhagia; Menstruation; Retrospective Studies; Young Adult | 2020 |
Intrauterine Device Use in Adolescents With Disabilities.
Topics: Adolescent; Amenorrhea; Child; Disabled Persons; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Retrospective Studies; Young Adult | 2020 |
Safety and bleeding patterns of the levonorgestrel 52-mg intrauterine system among women with thrombosis or coagulopathy.
Topics: Adult; Amenorrhea; Anticoagulants; Blood Coagulation Disorders; Brazil; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Oligomenorrhea; Retrospective Studies; Thromboembolism; Thrombosis | 2020 |
[Safety and acceptability of the 52 mg levonorgestrel-releasing intrauterine system in women with abnormal uterine bleeding in an ambulatory care center in Bogotá, Colombia, 2012-2016].
Topics: Adult; Amenorrhea; Cohort Studies; Colombia; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Retrospective Studies; Ultrasonography; Uterine Hemorrhage; Uterus | 2020 |
Comparing bleeding patterns for the levonorgestrel 52 mg, 19.5 mg, and 13.5 mg intrauterine systems.
Topics: Amenorrhea; Dose-Response Relationship, Drug; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia | 2019 |
Menstrual Suppression in Pediatric and Adolescent Patients with Disabilities Ranging from Developmental to Acquired Conditions: A Population Study in an Australian Quaternary Pediatric and Adolescent Gynecology Service from January 2005 to December 2015.
Topics: Adolescent; Amenorrhea; Australia; Child; Contraceptives, Oral, Hormonal; Disabled Persons; Female; Humans; Levonorgestrel; Menstruation; Retrospective Studies; Young Adult | 2019 |
Pain and bleeding pattern related to levonorgestrel intrauterine system (LNG-IUS) insertion.
Topics: Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pain; Parity; Pregnancy; Prospective Studies; Ultrasonography; Uterus | 2013 |
A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system.
Topics: Adult; Age Factors; Amenorrhea; Australia; Contraception; Contraceptive Agents, Female; Desogestrel; Device Removal; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Longitudinal Studies; Marital Status; Metrorrhagia; Parity; Patient Satisfaction; Young Adult | 2014 |
Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use.
Topics: Abortion, Induced; Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Menorrhagia; Multivariate Analysis; Pregnancy; Pregnancy, Unplanned; Prospective Studies; United States; Young Adult | 2016 |
Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada.
Topics: Adolescent; Adult; Amenorrhea; Canada; Clinical Trials, Phase III as Topic; Contraceptives, Oral, Combined; Dosage Forms; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Menorrhagia; Metrorrhagia; Middle Aged; Multicenter Studies as Topic; Patient Satisfaction; Young Adult | 2010 |
Amenorrhea and BMI as independent determinants of patient satisfaction in LNG-IUD users: cross-sectional study in a Central European district.
Topics: Adult; Amenorrhea; Body Mass Index; Contraceptive Agents, Female; Cross-Sectional Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Patient Satisfaction; Surveys and Questionnaires | 2012 |
Endometrial histopathology, ovarian changes and bleeding patterns among users of long-acting progestin-only contraceptives in Egypt.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Desogestrel; Dose-Response Relationship, Drug; Egypt; Endometrium; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Ovarian Follicle; Progestins; Time Factors; Ultrasonography | 2012 |
Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
Topics: Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormones; Injections; Intrauterine Devices; Lactation; Levonorgestrel; Menstrual Cycle; Menstruation; Menstruation Disturbances; Norethindrone; Physiology; Pregnancy; Progesterone; Progestins; Reproduction; Signs and Symptoms | 1982 |
Subdermal levonorgestrel implants and pituitary function.
Topics: Age Factors; Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endocrine System; Family Planning Services; Follicle Stimulating Hormone; Gonadotropins; Gonadotropins, Pituitary; Hormones; Levonorgestrel; Luteinizing Hormone; Menstruation; Menstruation Disturbances; Parity; Physiology; Pituitary Gland; Pituitary Hormones; Prolactin; Reproduction; Reproductive Control Agents | 1983 |
Prospective experience with a levonorgestrel implant--Norplant.
Topics: Age Factors; Amenorrhea; Americas; Anthropometry; Behavior; Biology; Body Weight; Colombia; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Demography; Developed Countries; Developing Countries; Diagnosis; Disease; Dysmenorrhea; Educational Status; Endocrine System; Evaluation Studies as Topic; Family Planning Services; Fertility; Headache; Hemorrhage; Hormones; Incidence; Latin America; Levonorgestrel; Menstrual Cycle; Menstruation; Menstruation Disturbances; Neurologic Manifestations; Parity; Patient Acceptance of Health Care; Physiology; Population; Population Characteristics; Population Dynamics; Reproduction; Reproductive Control Agents; Research; Research Design; Sexual Behavior; Signs and Symptoms; South America; Statistics as Topic | 1984 |
Users' perspectives on bleeding patterns after two years of levonorgestrel-releasing intrauterine system use.
Topics: Adult; Amenorrhea; Brazil; Cross-Sectional Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Patient Satisfaction | 2002 |
Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study.
Topics: Adult; Amenorrhea; Attitude; Coitus; Contraceptive Agents, Female; Dysmenorrhea; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Menstruation; Middle Aged; Patient Satisfaction; Pregnancy | 2003 |
[Tolerance and acceptability of Norplant contraceptive devices].
Topics: Adolescent; Adult; Amenorrhea; Asthenia; Contraception; Contraceptives, Oral, Synthetic; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Patient Satisfaction; Prospective Studies; Senegal; Silicone Elastomers; Uterine Hemorrhage | 2002 |
Correlation between endometrial histology, microvascular density and calibre, matrix metalloproteinase-3 and bleeding pattern in women using a levonorgestrel-releasing intrauterine system.
Topics: Adult; Amenorrhea; Biopsy; Contraceptive Agents, Female; Endometrium; Female; Humans; Leukocytes; Levonorgestrel; Matrix Metalloproteinase 3; Menstruation; Microcirculation; Stromal Cells | 2004 |
Histological characteristics and altered expression of interleukins (IL) IL-13 and IL-15 in endometria of levonorgestrel users with different uterine bleeding patterns.
Topics: Amenorrhea; Biomarkers; Biopsy; Contraceptives, Oral, Synthetic; Endometrium; Estradiol; Female; Humans; Interleukin-13; Interleukin-15; Levonorgestrel; Menorrhagia; Menstruation; Patient Compliance; Progesterone; Surveys and Questionnaires | 2005 |
Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Topics: Adult; Amenorrhea; Cohort Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Oligomenorrhea; Prospective Studies; Time Factors; Treatment Outcome; Uterine Neoplasms; Uterus | 2007 |
[Pathogenetic correction of reproductive function disorder in patients with normogonadotropic ovary deficiency caused by body mass deficiency].
Topics: Adolescent; Adult; Amenorrhea; Body Mass Index; Drug Combinations; Dydrogesterone; Emaciation; Estradiol; Female; Gonadotropins; Humans; Infertility, Female; Levonorgestrel; Primary Ovarian Insufficiency | 2007 |
Analysis of weight, packed cell volume changes and menstrual pattern in Norplant implant acceptors in Ilorin, Nigeria.
Topics: Adult; Amenorrhea; Body Weight; Contraceptive Agents, Female; Female; Hematocrit; Humans; Levonorgestrel; Menstruation; Nigeria; Prospective Studies | 2007 |
A new ultra-low-dose combination oral contraceptive.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Stereoisomerism | 1983 |
Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device.
Topics: Adult; Amenorrhea; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Devices; Levonorgestrel; Menstruation; Norgestrel; Ovary | 1984 |
Duration of breast-feeding and development of children after insertion of a levonorgestrel-releasing intrauterine contraceptive device.
Topics: Adolescent; Adult; Amenorrhea; Apgar Score; Breast Feeding; Female; Humans; Infant, Newborn; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Male; Norgestrel; Otitis Media; Postpartum Period; Pregnancy; Respiratory Tract Infections; Sex Ratio | 1982 |
Effects of oestradiol on sex hormone binding globulin.
Topics: Adult; Amenorrhea; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol; Female; Humans; Levonorgestrel; Menopause; Menotropins; Menstruation; Norgestrel; Ovulation; Progesterone; Sex Hormone-Binding Globulin | 1982 |
Body iron stores and patterns of bleeding after insertion of a levonorgestrel- or a copper-releasing intrauterine contraceptive device.
Topics: Amenorrhea; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Erythrocyte Count; Erythrocyte Indices; Female; Ferritins; Hematocrit; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Norgestrel; Postpartum Period; Pregnancy | 1982 |
A cohort study of Norplant implant: side-effects and acceptance.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Cohort Studies; Contraceptive Agents, Female; Drug Implants; Female; Humans; Indonesia; Intrauterine Devices; Levonorgestrel; Menstruation Disturbances; Patient Satisfaction; Pregnancy; Pregnancy Rate; Risk Factors; Surveys and Questionnaires; Uterine Hemorrhage | 1995 |
Hormonal intrauterine devices.
Topics: Adolescent; Adult; Amenorrhea; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pelvic Inflammatory Disease; Pregnancy; Sweden; Uterine Hemorrhage | 1993 |
[Pregnancy and hormone replacement therapy in a patient with resistant ovary syndrome].
Topics: Adult; Amenorrhea; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Infertility, Female; Levonorgestrel; Pregnancy; Pregnancy Outcome; Primary Ovarian Insufficiency | 1999 |
Amenorrhoea despite displaced levonorgestrel intra-uterine system.
Topics: Adult; Amenorrhea; Back Pain; Contraceptive Agents, Female; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Progesterone Congeners; Uterine Perforation | 2000 |
Endometrial expression of glycodelin in women with levonorgestrel-releasing subdermal implants.
Topics: Adult; Aged; Amenorrhea; Biopsy; Contraceptive Agents, Female; Cross-Sectional Studies; Curettage; Drug Implants; Endometrium; Female; Gene Expression Regulation; Glycodelin; Glycoproteins; Humans; Hysterectomy; Immunohistochemistry; In Situ Hybridization; Levonorgestrel; Menstrual Cycle; Middle Aged; Observer Variation; Postmenopause; Pregnancy Proteins; RNA, Messenger; Single-Blind Method; Transcription, Genetic | 2001 |
Hormonal changes associated with bleeding during low dose progestogen contraception delivered by Norplant subdermal implants.
Topics: Amenorrhea; Contraceptive Agents, Female; Drug Implants; Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Norgestrel; Oligomenorrhea; Progesterone | 1991 |
Norplant contraceptive subdermal implants: two-year experience in Singapore.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Norgestrel; Singapore | 1989 |
Menstrual changes associated with progestogen-only contraception.
Topics: Administration, Oral; Amenorrhea; Contraceptive Agents, Female; Counseling; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norgestrel; Time Factors | 1986 |
Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.
Topics: Adult; Amenorrhea; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Life Style; Menstrual Cycle; Norgestrel; Norpregnenes | 1987 |